CanAssist Breast Test examines the activity of proteins present in the cancerous tumour to predict the likelihood of the cancer returning post- surgery. It also helps determine whether chemotherapy will benefit the patient or whether just hormone therapy by itself is sufficient. So patients should not hesitate to ask their doctors how CanAssist Breast Test results may impact their treatment plan. CanAssist Breast provides additional information about the tumor, based on which the cancer treatment can be customized.
Once your doctor prescribes CanAssist Breast, the hospital laboratory will send your tumour sample (FFPE blocks) to OncoStem’s laboratory. Our lab performs the test and shares the report with your doctor within ten business days.